Protagonist Therapeutics, Inc. · NASDAQ:PTGX

BlackRock, Inc. reported a 13.80% stake in Protagonist Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 17, 2025

BlackRock, Inc. reported a 13.80% stake in Protagonist Therapeutics, Inc., 8,575,669 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).

Stake
13.80%
Shares
8,575,669
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.13.80%8,575,669

Source

View original at SEC

Related